2009-11-10 13:45:02 -
Kuros Biosurgery AG - Medical Equipment - Deals and Alliances Profile - a new market research report on companiesandmarkets.com www.companiesandmarkets.com/Summary-Company-Profile/kuros-biosur ..
Kuros Biosurgery AG - Medical Equipment - Deals and Alliances Profile
Summary
Kuros Biosurgery AG (Kuros) is a biomedical company engaged in the development of biomaterial products. It develops a broad range of bioactive wound care products, bone graft substitutes, bioactive spinal products and sealants. Its hard and soft tissue repair products are used in biosurgery and orthobiologics markets. Bioactive bone graft
substitute intended for in-situ treatment of various long bone indications. Kuros bioactive spinal products intended for the treatment of various spinal indications. It develops dural sealants using its synthetic biomaterial technology.
The Kuros Biosurgery AG - Medical Equipment - Deals and Alliances Profile is an essential source for company data and information. The profile examines the companys key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the companys major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the companys major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.